Dr. Emilio Porfiri qualified in Medicine in 1982 and specialised in Oncology in 1985. He was awarded a PhD from the Royal Free Hospital School of Medicine, London, in 1993. From 1992 until 1997 he worked at ONYX Pharmaceuticals, Richmond, California, participating in the development of novel cancer therapeutics. From 1997 until 2003 he was a Lecturer and Honorary Consultant in Medical Oncology at the University of Ancona, Italy.
Between August 2003 and September 2012 he was Senior Lecturer in Medical Oncology at the University of Birmingham, from October 2012 he is Consultant Medical Oncologist at the Queen Elizabeth Hospital Birmingham. Dr Porfiri’s sites of specialist interest are: tumours of the kidney, testis, prostate and bladder. He is currently Clinical Lead of the Testicular Cancer Service at the Queen Elizabeth Hospital Birmingham. His main scientific interests are the study of new targeted treatments for renal cancer, in particular new tyrosine kinase inhibitors, and the management relapsed testicular tumours.